IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GHEZZI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.795
NA - Nord America 4.729
EU - Europa 4.352
SA - Sud America 479
AF - Africa 126
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.512
SG - Singapore 1.470
CN - Cina 1.433
GB - Regno Unito 1.206
IT - Italia 857
DE - Germania 430
HK - Hong Kong 420
BD - Bangladesh 416
SE - Svezia 403
BR - Brasile 366
RU - Federazione Russa 345
VN - Vietnam 329
FR - Francia 240
IN - India 208
NL - Olanda 158
IE - Irlanda 146
CA - Canada 132
FI - Finlandia 125
JP - Giappone 97
KR - Corea 86
DK - Danimarca 82
ES - Italia 79
TR - Turchia 76
ID - Indonesia 62
BE - Belgio 51
PL - Polonia 45
MX - Messico 42
CI - Costa d'Avorio 37
AR - Argentina 36
UA - Ucraina 35
AT - Austria 32
MA - Marocco 30
AU - Australia 29
IQ - Iraq 29
IR - Iran 26
GR - Grecia 22
PK - Pakistan 20
VE - Venezuela 16
PH - Filippine 15
RO - Romania 15
ZA - Sudafrica 15
CO - Colombia 14
PE - Perù 14
UZ - Uzbekistan 14
CZ - Repubblica Ceca 12
EC - Ecuador 12
IL - Israele 11
PT - Portogallo 11
EG - Egitto 10
KZ - Kazakistan 9
TW - Taiwan 9
CH - Svizzera 8
CL - Cile 8
JM - Giamaica 8
JO - Giordania 8
LU - Lussemburgo 8
MY - Malesia 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
NO - Norvegia 7
PY - Paraguay 7
SA - Arabia Saudita 7
CR - Costa Rica 6
DZ - Algeria 6
EU - Europa 6
AL - Albania 5
HN - Honduras 5
HU - Ungheria 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
LT - Lituania 4
NP - Nepal 4
PR - Porto Rico 4
QA - Qatar 4
UY - Uruguay 4
BB - Barbados 3
BH - Bahrain 3
CU - Cuba 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
KE - Kenya 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NG - Nigeria 2
OM - Oman 2
Totale 14.498
Salva come PNG Salva come JPEG
Città #
Southend 1.006
Singapore 846
Ashburn 547
Hong Kong 373
San Jose 305
Chandler 303
Milan 285
Beijing 210
Ann Arbor 192
Fairfield 166
Seattle 165
Council Bluffs 155
New York 147
Dublin 137
Princeton 135
Santa Clara 131
Los Angeles 127
Dallas 124
Wilmington 118
Houston 102
Ho Chi Minh City 91
Lauterbourg 86
Woodbridge 85
Berlin 77
Guangzhou 77
Hanoi 73
Helsinki 73
Nanjing 73
Bengaluru 69
Buffalo 69
Hefei 69
Cambridge 67
Toronto 65
Shanghai 64
Kent 63
Moscow 63
Frankfurt am Main 62
Boardman 61
Redwood City 57
The Dalles 57
Tokyo 53
Des Moines 44
Jakarta 44
Dearborn 43
Brussels 41
Jinan 40
Phoenix 40
Rome 39
Abidjan 37
Shenyang 35
Cangzhou 33
Naples 33
Turin 33
Columbus 32
Tianjin 30
London 27
São Paulo 24
Bühl 23
Changsha 23
Chicago 22
Istanbul 22
Munich 22
Nanchang 22
Ottawa 22
Seoul 22
Dong Ket 21
Fuzhou 21
Shenzhen 20
Hangzhou 19
Norwalk 19
Warsaw 19
Athens 18
Amsterdam 17
Barcelona 17
Central District 17
Nuremberg 17
Redmond 16
Haiphong 15
Rio de Janeiro 14
Vienna 14
Washington 14
Bologna 13
Düsseldorf 13
Hebei 13
Madrid 13
Mountain View 13
Orem 13
Silver Spring 13
Baghdad 12
Montreal 12
Mumbai 12
San Francisco 12
Zhengzhou 12
Atlanta 11
Casablanca 11
Chennai 11
Paris 11
Wuhan 11
Andover 10
Brescia 10
Totale 8.285
Salva come PNG Salva come JPEG
Nome #
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis? 533
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 519
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 335
Usefulness of multi-parametric MRI for the investigation of posterior cortical atrophy 296
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 295
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 279
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis 265
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 264
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status 260
Causal frontotemporal de generation mutations : a novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 255
Behavioral and Neurophysiological Effects of Transcranial Direct Current Stimulation (tDCS) in Fronto-Temporal Dementia 254
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis 253
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients 239
Validation of the Italian Addenbrooke’s cognitive examination revised (ACE-R) as a screening test 236
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 234
Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations 231
Circulating miRNAs as potential biomarkers in Alzheimer's disease 224
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 221
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 221
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 215
Causal frontotemporal lobar degeneration mutations : a novel mutation in MAPT associated with non-fluent Progressive Aphasia phenotype 213
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 211
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred 208
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes 208
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 204
A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation 203
Disease-modifying drugs in Alzheimer's disease 203
UNRAVELLING THE ROLE OF MUCOSAL ASSOCIATED INVARIANT T CELLS IN THE PATHOGENESIS OF MULTIPLE SCLEROSIS AND ITS ANIMAL MODEL 200
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 194
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred 190
Alterations of host-gut microbiome interactions in multiple sclerosis 190
Inflammatory molecules in Frontotemporal Dementia : Cerebrospinal fluid signature of progranulin mutation carriers 189
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with alzheimer's disease 188
Sciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathy 186
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation 184
GRN Asp22fs mutation is associated with highly variable age at onset, clinical phenotype and brain atrophy 180
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 177
A “glympse” into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin‐4 for the assessment of glymphatic system in Alzheimer's disease and other dementias 177
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy 175
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease 174
Why Is Multiple Sclerosis More Frequent in Women? Role of the Immune System and of Oral and Gut Microbiota 173
Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod 170
Early onset behavioral variant frontotemporal Dementia due to the C9ORF72 Hexanucleotide Repeat Expansion: Psychiatric Clinical Presentations 168
Phenotypic heterogeneity of the progranulin gene Asp22fs mutation in a large Italian kindred 164
The impact of osteopontin gene variations on multiple sclerosis development and progression 164
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 161
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 157
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 153
The influence of hormonal contraception on depression and female sexuality: a narrative review of the literature 152
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 149
GRN Asp22fs mutation is associated with heterogeneous neurodegenerative clinical phenotypes 148
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome 146
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis [Low CSF beta-amyloid levels predict early regional grey matter atrophy in multiple sclerosis] 144
The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases 143
Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota 143
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration 140
Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia − A GENFI study 140
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration 132
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 131
A case of vanishing white matter disease due to the c.260C > T(p.Ala87Val) EIF2B3 mutation 127
Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation 116
A case of vanishing white-matter disease due to the c.260C>T (p.Ala87Val) EIF2B3 mutation 116
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study 114
Frequency of the C9ORF72 hexanucleotide repeat expansion in Italian non demented elderly subjects 110
Immunotherapy against amyloid pathology in Alzheimer's disease 108
Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease 107
Causal frontotemporal degeneration mutations : a novel MAPT mutation associated with clinical phenotype of progressive nonfluent aphasia 105
Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity 104
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 102
T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients 98
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis 96
Two cases of early onset FTLD due to chromosome 9 hexanucleotide repeats 93
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases 91
CSF sphingolipids are correlated with neuroinflammatory cytokines and differentiate neuromyelitis optica spectrum disorder from multiple sclerosis 91
Cognitive predictors and correlations with biomarkers and functional imaging in patients with primary progressive aphasia 89
Energy restriction in people with multiple sclerosis: Is time more important than calories? 85
Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction 84
Frequency of autosomal dominant mutations in an Italian population of patients with frontotemporal lobar degeneration 84
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis 81
Schwann cell remyelination in the multiple sclerosis central nervous system 80
Alzheimer's disease: Clinical aspects and treatments 77
Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients 75
Frequency of autosomal dominant mutations in an Italian population of patients with frontotemporal lobar degeneration 73
Association between Klotho levels in cerebrospinal fluid and choroid plexus enlargement in neurodegeneration 69
Targeting the gut to treat multiple sclerosis 67
Diagnosis of alzheimer’s disease typical and atypical forms 66
Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative diseases 64
Alterations of the gut mycobiome in patients with MS 63
From diagnosis to disease staging: multisite validation of cerebrospinal fluid molecular tests in multiple sclerosis 61
The serum lipid profile of relapsing multiple sclerosis differs reproducibly from healthy controls 54
Totale 15.111
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021162 0 0 0 0 0 0 0 0 0 0 0 162
2021/2022938 100 62 33 37 46 58 77 89 104 81 82 169
2022/20231.310 152 156 107 129 124 243 41 84 127 27 85 35
2023/20241.024 34 74 68 72 227 60 73 90 45 68 98 115
2024/20252.610 51 293 79 235 192 108 156 243 129 271 219 634
2025/20265.384 544 313 446 447 433 297 665 245 610 375 841 168
Totale 15.111